Literature DB >> 24029224

It takes a CAD to kill a tumor cell with a LMP.

Erich Gulbins1, Richard N Kolesnick.   

Abstract

Cancer cells display lysosome hypertrophy, secreting lysosomal hydrolases for tumor progression. Hypertrophy renders lysosomes fragile, increasing lysosomal membrane permeabilization (LMP) tendency. In this issue of Cancer Cell, Petersen and colleagues show that lysosomal sphingomyelin content determines LMP and cationic drugs displace acid sphingomyelinase from lysosomal membranes, increasing tumor LMP and death.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24029224     DOI: 10.1016/j.ccr.2013.08.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  8 in total

Review 1.  Insight into nanoparticle cellular uptake and intracellular targeting.

Authors:  Basit Yameen; Won Il Choi; Cristian Vilos; Archana Swami; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

2.  Lysosomes in glioblastoma: pump up the volume.

Authors:  Kathryn A Jacobs; Clément Maghe; Julie Gavard
Journal:  Cell Cycle       Date:  2020-07-29       Impact factor: 4.534

3.  APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.

Authors:  Xiqian Lan; Aakash Jhaveri; Kang Cheng; Hongxiu Wen; Moin A Saleem; Peter W Mathieson; Joanna Mikulak; Sharon Aviram; Ashwani Malhotra; Karl Skorecki; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-04

Review 4.  Subcellular Performance of Nanoparticles in Cancer Therapy.

Authors:  Chen-Guang Liu; Ya-Hui Han; Ranjith Kumar Kankala; Shi-Bin Wang; Ai-Zheng Chen
Journal:  Int J Nanomedicine       Date:  2020-02-05

Review 5.  Repurposing Cationic Amphiphilic Drugs and Derivatives to Engage Lysosomal Cell Death in Cancer Treatment.

Authors:  Michelle Hu; Kermit L Carraway
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

6.  Nanoparticle core stability and surface functionalization drive the mTOR signaling pathway in hepatocellular cell lines.

Authors:  Mariia Lunova; Andrey Prokhorov; Milan Jirsa; Martin Hof; Agnieszka Olżyńska; Piotr Jurkiewicz; Šárka Kubinová; Oleg Lunov; Alexandr Dejneka
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

Review 7.  Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy.

Authors:  Antoni Domagala; Klaudyna Fidyt; Malgorzata Bobrowicz; Joanna Stachura; Kacper Szczygiel; Malgorzata Firczuk
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

8.  The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma.

Authors:  Sylvia Faict; Inge Oudaert; Ludovic D'Auria; Jonas Dehairs; Ken Maes; Philip Vlummens; Kim De Veirman; Elke De Bruyne; Karel Fostier; Isabelle Vande Broek; Rik Schots; Karin Vanderkerken; Johannes V Swinnen; Eline Menu
Journal:  Cancers (Basel)       Date:  2019-11-20       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.